Literature DB >> 4172531

Treatment of benign prostatic hypertrophy with progestational agents: a preliminary report.

H Wolf, P O Madsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4172531     DOI： 10.1016/s0022-5347(17)62793-9

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  6 in total

1.  Antiandrogenic treatment of benign prostatic hyperplasia: a placebo controlled trial.

Authors:  P Ostri; R Swartz; H H Meyhoff; J H Petersen; G Lindgård; C Frimodt-Møller; T Andersson; M S Nielsen
Journal:  Urol Res       Date:  1989

2.  Effects of cimetidine, progesterone, cannitracin and tolazoline on the weight and DNA content of the testosterone-induced hyperplastic prostate of the rat.

Authors:  W Chen; X M Zhou; D Y Chen; J S Kang
Journal:  Urol Res       Date:  1988

3.  Pills for the benign prostate. Trial designs.

Authors:  J E Castro
Journal:  Proc R Soc Med       Date:  1972-02

4.  Shrinking the prostate.

Authors: 
Journal:  Br Med J       Date:  1970-03-07

5.  Candicidin treatment of prostatism: a prospective double-blind placebo-controlled study.

Authors:  K M Jensen; P O Madsen
Journal:  Urol Res       Date:  1983

6.  Benign prostatic hyperplasia: An overview of existing treatment.

Authors:  Neelima Dhingra; Deepak Bhagwat
Journal:  Indian J Pharmacol       Date:  2011-02       Impact factor: 1.200
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.